Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Hyperprolactinemia and DRD3[original query] |
|---|
| Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients. Progress in neuro-psychopharmacology & biological psychiatry 2008 Aug 32 (6): 1491-5. Yasui-Furukori Norio, Saito Manabu, Tsuchimine Shoko, Nakagami Taku, Sato Yasushi, Sugawara Norio, Kaneko Sun |
| DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers. Journal of clinical psychopharmacology 2011 Oct 31 (5): 555-62. López-Rodríguez Rosario, Román Manuel, Novalbos Jesús, Pelegrina Maria Laura, Ochoa Dolores, Abad-Santos Francis |
| A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. BMC medical genetics 2019 Apr 20 (Suppl 1): 47. Osmanova Diana Z, Freidin Maxim B, Fedorenko Olga Yu, Pozhidaev Ivan V, Boiko Anastasiia S, Vyalova Natalia M, Tiguntsev Vladimir V, Kornetova Elena G, Loonen Anton J M, Semke Arkadiy V, Wilffert Bob, Bokhan Nikolay A, Ivanova Svetlana |
| Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review. Canadian journal of psychiatry. Revue canadienne de psychiatrie 2020 11 66 (12): 1019-1041. Yoshida Kazunari, Koyama Emiko, Zai Clement C, Beitchman Joseph H, Kennedy James L, Lunsky Yona, Desarkar Pushpal, Müller Daniel |
- Page last reviewed:Feb 1, 2024
- Content source: